0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Opioid Narcotics Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-35X18021
Home | Market Reports | Sensitive Subjects
Global Opioid Narcotics Market Research Report 2024
BUY CHAPTERS

Global Opioid Narcotics Market Research Report 2024

Code: QYRE-Auto-35X18021
Report
September 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Opioid Narcotics Market

Opioids are a class of drugs derived from the poppy plant or obtained through synthetic routes. They are mainly used to relieve moderate to severe pain and, in some cases, for anesthesia. These drugs bind to opioid receptors in the central nervous system to exert a variety of effects such as analgesia and sedation.
The global Opioid Narcotics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Opioid Narcotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Pfizer, Fresenius Kabi, Daiichi Sankyo, Abbott, GSK, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioid Narcotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Narcotics.
The Opioid Narcotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Opioid Narcotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Narcotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Opioid Narcotics Market Report

Report Metric Details
Report Name Opioid Narcotics Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Pfizer, Fresenius Kabi, Daiichi Sankyo, Abbott, GSK, Reig Jofre, AcelRx Pharmaceuticals, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Opioid Narcotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Opioid Narcotics Market report?

Ans: The main players in the Opioid Narcotics Market are Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Pfizer, Fresenius Kabi, Daiichi Sankyo, Abbott, GSK, Reig Jofre, AcelRx Pharmaceuticals, Inc

What are the Application segmentation covered in the Opioid Narcotics Market report?

Ans: The Applications covered in the Opioid Narcotics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Opioid Narcotics Market report?

Ans: The Types covered in the Opioid Narcotics Market report are Fentanyl, Remifentanil, Sufentanil

Recommended Reports

Pain Relief Drugs

Opioids & Addiction

Chronic & Post-operative

1 Opioid Narcotics Market Overview
1.1 Product Definition
1.2 Opioid Narcotics by Type
1.2.1 Global Opioid Narcotics Market Value Comparison by Type (2024-2030)
1.2.2 Fentanyl
1.2.3 Remifentanil
1.2.4 Sufentanil
1.3 Opioid Narcotics by Application
1.3.1 Global Opioid Narcotics Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Opioid Narcotics Market Size Estimates and Forecasts
1.4.1 Global Opioid Narcotics Revenue 2019-2030
1.4.2 Global Opioid Narcotics Sales 2019-2030
1.4.3 Global Opioid Narcotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Opioid Narcotics Market Competition by Manufacturers
2.1 Global Opioid Narcotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Opioid Narcotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Opioid Narcotics Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Opioid Narcotics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioid Narcotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Narcotics, Product Type & Application
2.7 Global Key Manufacturers of Opioid Narcotics, Date of Enter into This Industry
2.8 Global Opioid Narcotics Market Competitive Situation and Trends
2.8.1 Global Opioid Narcotics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Opioid Narcotics Players Market Share by Revenue
2.8.3 Global Opioid Narcotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Opioid Narcotics Market Scenario by Region
3.1 Global Opioid Narcotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Opioid Narcotics Sales by Region: 2019-2030
3.2.1 Global Opioid Narcotics Sales by Region: 2019-2024
3.2.2 Global Opioid Narcotics Sales by Region: 2025-2030
3.3 Global Opioid Narcotics Revenue by Region: 2019-2030
3.3.1 Global Opioid Narcotics Revenue by Region: 2019-2024
3.3.2 Global Opioid Narcotics Revenue by Region: 2025-2030
3.4 North America Opioid Narcotics Market Facts & Figures by Country
3.4.1 North America Opioid Narcotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Opioid Narcotics Sales by Country (2019-2030)
3.4.3 North America Opioid Narcotics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Opioid Narcotics Market Facts & Figures by Country
3.5.1 Europe Opioid Narcotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Opioid Narcotics Sales by Country (2019-2030)
3.5.3 Europe Opioid Narcotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Narcotics Market Facts & Figures by Region
3.6.1 Asia Pacific Opioid Narcotics Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Opioid Narcotics Sales by Region (2019-2030)
3.6.3 Asia Pacific Opioid Narcotics Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Opioid Narcotics Market Facts & Figures by Country
3.7.1 Latin America Opioid Narcotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Opioid Narcotics Sales by Country (2019-2030)
3.7.3 Latin America Opioid Narcotics Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Opioid Narcotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Narcotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Opioid Narcotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Opioid Narcotics Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Opioid Narcotics Sales by Type (2019-2030)
4.1.1 Global Opioid Narcotics Sales by Type (2019-2024)
4.1.2 Global Opioid Narcotics Sales by Type (2025-2030)
4.1.3 Global Opioid Narcotics Sales Market Share by Type (2019-2030)
4.2 Global Opioid Narcotics Revenue by Type (2019-2030)
4.2.1 Global Opioid Narcotics Revenue by Type (2019-2024)
4.2.2 Global Opioid Narcotics Revenue by Type (2025-2030)
4.2.3 Global Opioid Narcotics Revenue Market Share by Type (2019-2030)
4.3 Global Opioid Narcotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Opioid Narcotics Sales by Application (2019-2030)
5.1.1 Global Opioid Narcotics Sales by Application (2019-2024)
5.1.2 Global Opioid Narcotics Sales by Application (2025-2030)
5.1.3 Global Opioid Narcotics Sales Market Share by Application (2019-2030)
5.2 Global Opioid Narcotics Revenue by Application (2019-2030)
5.2.1 Global Opioid Narcotics Revenue by Application (2019-2024)
5.2.2 Global Opioid Narcotics Revenue by Application (2025-2030)
5.2.3 Global Opioid Narcotics Revenue Market Share by Application (2019-2030)
5.3 Global Opioid Narcotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Yichang Renfu Pharmaceutical Co., Ltd.
6.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
6.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
6.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
6.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
6.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
6.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Henan Lingrui Pharmaceutical Co., Ltd.
6.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
6.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
6.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
6.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
6.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Description and Business Overview
6.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
6.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments/Updates
6.5 Changzhou Siyao Pharmaceutical Co., Ltd.
6.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
6.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
6.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Opioid Narcotics Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Fresenius Kabi
6.7.1 Fresenius Kabi Company Information
6.7.2 Fresenius Kabi Description and Business Overview
6.7.3 Fresenius Kabi Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Fresenius Kabi Opioid Narcotics Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Company Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 Abbott
6.9.1 Abbott Company Information
6.9.2 Abbott Description and Business Overview
6.9.3 Abbott Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbott Opioid Narcotics Product Portfolio
6.9.5 Abbott Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK Opioid Narcotics Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Reig Jofre
6.11.1 Reig Jofre Company Information
6.11.2 Reig Jofre Description and Business Overview
6.11.3 Reig Jofre Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Reig Jofre Opioid Narcotics Product Portfolio
6.11.5 Reig Jofre Recent Developments/Updates
6.12 AcelRx Pharmaceuticals, Inc
6.12.1 AcelRx Pharmaceuticals, Inc Company Information
6.12.2 AcelRx Pharmaceuticals, Inc Description and Business Overview
6.12.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
6.12.5 AcelRx Pharmaceuticals, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Narcotics Industry Chain Analysis
7.2 Opioid Narcotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Narcotics Production Mode & Process
7.4 Opioid Narcotics Sales and Marketing
7.4.1 Opioid Narcotics Sales Channels
7.4.2 Opioid Narcotics Distributors
7.5 Opioid Narcotics Customers
8 Opioid Narcotics Market Dynamics
8.1 Opioid Narcotics Industry Trends
8.2 Opioid Narcotics Market Drivers
8.3 Opioid Narcotics Market Challenges
8.4 Opioid Narcotics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Opioid Narcotics Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Opioid Narcotics Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Opioid Narcotics Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Opioid Narcotics Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Opioid Narcotics Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Opioid Narcotics Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Opioid Narcotics Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Opioid Narcotics Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Opioid Narcotics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Opioid Narcotics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Opioid Narcotics, Product Type & Application
 Table 12. Global Key Manufacturers of Opioid Narcotics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Opioid Narcotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Narcotics as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Opioid Narcotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Opioid Narcotics Sales by Region (2019-2024) & (K Units)
 Table 18. Global Opioid Narcotics Sales Market Share by Region (2019-2024)
 Table 19. Global Opioid Narcotics Sales by Region (2025-2030) & (K Units)
 Table 20. Global Opioid Narcotics Sales Market Share by Region (2025-2030)
 Table 21. Global Opioid Narcotics Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Opioid Narcotics Revenue Market Share by Region (2019-2024)
 Table 23. Global Opioid Narcotics Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Opioid Narcotics Revenue Market Share by Region (2025-2030)
 Table 25. North America Opioid Narcotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Opioid Narcotics Sales by Country (2019-2024) & (K Units)
 Table 27. North America Opioid Narcotics Sales by Country (2025-2030) & (K Units)
 Table 28. North America Opioid Narcotics Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Opioid Narcotics Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Opioid Narcotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Opioid Narcotics Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Opioid Narcotics Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Opioid Narcotics Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Opioid Narcotics Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Opioid Narcotics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Opioid Narcotics Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Opioid Narcotics Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Opioid Narcotics Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Opioid Narcotics Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Opioid Narcotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Opioid Narcotics Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Opioid Narcotics Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Opioid Narcotics Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Opioid Narcotics Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Opioid Narcotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Opioid Narcotics Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Opioid Narcotics Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Opioid Narcotics Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Opioid Narcotics Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Opioid Narcotics Sales (K Units) by Type (2019-2024)
 Table 51. Global Opioid Narcotics Sales (K Units) by Type (2025-2030)
 Table 52. Global Opioid Narcotics Sales Market Share by Type (2019-2024)
 Table 53. Global Opioid Narcotics Sales Market Share by Type (2025-2030)
 Table 54. Global Opioid Narcotics Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Opioid Narcotics Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Opioid Narcotics Revenue Market Share by Type (2019-2024)
 Table 57. Global Opioid Narcotics Revenue Market Share by Type (2025-2030)
 Table 58. Global Opioid Narcotics Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Opioid Narcotics Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Opioid Narcotics Sales (K Units) by Application (2019-2024)
 Table 61. Global Opioid Narcotics Sales (K Units) by Application (2025-2030)
 Table 62. Global Opioid Narcotics Sales Market Share by Application (2019-2024)
 Table 63. Global Opioid Narcotics Sales Market Share by Application (2025-2030)
 Table 64. Global Opioid Narcotics Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Opioid Narcotics Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Opioid Narcotics Revenue Market Share by Application (2019-2024)
 Table 67. Global Opioid Narcotics Revenue Market Share by Application (2025-2030)
 Table 68. Global Opioid Narcotics Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Opioid Narcotics Price (US$/Unit) by Application (2025-2030)
 Table 70. Yichang Renfu Pharmaceutical Co., Ltd. Company Information
 Table 71. Yichang Renfu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product
 Table 74. Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
 Table 76. Jiangsu Enhua Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product
 Table 79. Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Henan Lingrui Pharmaceutical Co., Ltd. Company Information
 Table 81. Henan Lingrui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product
 Table 84. Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
 Table 86. Sinopharm Group Industrial Co., Ltd. Langfang Branch Description and Business Overview
 Table 87. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product
 Table 89. Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments/Updates
 Table 90. Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
 Table 91. Changzhou Siyao Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product
 Table 94. Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Pfizer Opioid Narcotics Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Fresenius Kabi Company Information
 Table 101. Fresenius Kabi Description and Business Overview
 Table 102. Fresenius Kabi Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Fresenius Kabi Opioid Narcotics Product
 Table 104. Fresenius Kabi Recent Developments/Updates
 Table 105. Daiichi Sankyo Company Information
 Table 106. Daiichi Sankyo Description and Business Overview
 Table 107. Daiichi Sankyo Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Daiichi Sankyo Opioid Narcotics Product
 Table 109. Daiichi Sankyo Recent Developments/Updates
 Table 110. Abbott Company Information
 Table 111. Abbott Description and Business Overview
 Table 112. Abbott Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Abbott Opioid Narcotics Product
 Table 114. Abbott Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. GSK Opioid Narcotics Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Reig Jofre Company Information
 Table 121. Reig Jofre Description and Business Overview
 Table 122. Reig Jofre Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Reig Jofre Opioid Narcotics Product
 Table 124. Reig Jofre Recent Developments/Updates
 Table 125. AcelRx Pharmaceuticals, Inc Company Information
 Table 126. AcelRx Pharmaceuticals, Inc Description and Business Overview
 Table 127. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product
 Table 129. AcelRx Pharmaceuticals, Inc Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Opioid Narcotics Distributors List
 Table 133. Opioid Narcotics Customers List
 Table 134. Opioid Narcotics Market Trends
 Table 135. Opioid Narcotics Market Drivers
 Table 136. Opioid Narcotics Market Challenges
 Table 137. Opioid Narcotics Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Opioid Narcotics
 Figure 2. Global Opioid Narcotics Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Opioid Narcotics Market Share by Type: 2023 & 2030
 Figure 4. Fentanyl Product Picture
 Figure 5. Remifentanil Product Picture
 Figure 6. Sufentanil Product Picture
 Figure 7. Global Opioid Narcotics Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Opioid Narcotics Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Opioid Narcotics Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Opioid Narcotics Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Opioid Narcotics Sales (2019-2030) & (K Units)
 Figure 15. Global Opioid Narcotics Average Price (US$/Unit) & (2019-2030)
 Figure 16. Opioid Narcotics Report Years Considered
 Figure 17. Opioid Narcotics Sales Share by Manufacturers in 2023
 Figure 18. Global Opioid Narcotics Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Opioid Narcotics Players: Market Share by Revenue in Opioid Narcotics in 2023
 Figure 20. Opioid Narcotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Opioid Narcotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Opioid Narcotics Sales Market Share by Country (2019-2030)
 Figure 23. North America Opioid Narcotics Revenue Market Share by Country (2019-2030)
 Figure 24. United States Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Opioid Narcotics Sales Market Share by Country (2019-2030)
 Figure 27. Europe Opioid Narcotics Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Opioid Narcotics Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Opioid Narcotics Revenue Market Share by Region (2019-2030)
 Figure 35. China Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Opioid Narcotics Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Opioid Narcotics Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Opioid Narcotics Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Opioid Narcotics Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Opioid Narcotics by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Opioid Narcotics by Type (2019-2030)
 Figure 54. Global Opioid Narcotics Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Opioid Narcotics by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Opioid Narcotics by Application (2019-2030)
 Figure 57. Global Opioid Narcotics Price (US$/Unit) by Application (2019-2030)
 Figure 58. Opioid Narcotics Value Chain
 Figure 59. Opioid Narcotics Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS